CompletedNCT01926912

A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting

Observational studyAges 18+Multiple countries

The study in practice

Understand this study

Listed age limits: from 18 years.

Listed locations: Diest and 38 more locationsSee all locations and recruitment

Study clarity

Study start dateMay 2013

Recruitment status: Completed
Enrollment listed in the registry: 371
Sponsor: Janssen-Cilag International NV
Sponsor type: Unknown or unclear
Study type: Observational
Intervention type: Medication / drug
Study phase: Not clearly listed
Locations: Belgium, Bulgaria, Denmark, ...
Age range: Over 18 Years
Official registry ID: NCT01926912
Official title: Show the full official title
HOSPItal Use of Paliperidone Palmitate - A Prospective Non-Interventional Study

Completed

Diest, Belgium · Saint-Servais, Belgium · Tournai, Belgium

37 more locations

FAQ

Who is behind this study?

The study sponsor is Janssen-Cilag International NV.

Who was this study for?

Listed age limits: from 18 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.